Preliminary analysis of risk factors for late rectal toxicity after helical tomotherapy for prostate cancer

Journal of Radiation Research

Volumn 54, Issue 5, 2013, Pages 919-924

  Tomita, Natsuo ^a   Soga, Norihito ^a   Ogura, Yuji ^a   Hayashi, Norio ^a   Shimizu, Hidetoshi ^a   Kubota, Takashi ^a   Ito, Junji ^a   Hirata, Kimiko ^a   Ohshima, Yukihiko ^a   Tachibana, Hiroyuki ^a   Kodaira, Takeshi ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Helical tomotherapy; Image guided radiation therapy; Intensity modulated radiation therapy; Late toxicity; Prostate cancer

Indexed keywords

DISEASES; DOSIMETRY; FACTOR ANALYSIS; GRADING; MULTIVARIANT ANALYSIS; ONCOLOGY; PATIENT MONITORING; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK MANAGEMENT; TOXICITY; UROLOGY;

FOLLOW UP; HELICAL TOMOTHERAPY; IMAGE-GUIDED RADIATION THERAPY; INTENSITY-MODULATED RADIATION THERAPY; LATE RECTAL TOXICITIES; LATE TOXICITIES; LOCALIZED PROSTATE CANCER; PROSTATE CANCERS; RISK FACTORS; STUDENT'S T TESTS;

RADIOTHERAPY;

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; IMAGE-GUIDED RADIATION THERAPY; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; JAPAN; KIDNEY DISEASE; LATE TOXICITY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATE TUMOR; RADIATION INJURY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; SURVIVAL RATE; TOMOTHERAPY; VERY ELDERLY;

HELICAL TOMOTHERAPY; IMAGE-GUIDED RADIATION THERAPY; INTENSITY-MODULATED RADIATION THERAPY; LATE TOXICITY; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; HUMANS; INCIDENCE; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84888211626     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt025     Document Type: Article

References (17)

1. Peeters ST, Lebesque JV, Heemsbergen WD et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2006;64:1151-61
2. Vavassori V, Fiorino C, Rancati T et al. Predictors for rectal and intestinal acute toxicities during prostate cancer highdose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 2007;67:1401-10
3. Skwarchuk MW, Jackson A, Zelefsky MJ et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000;47:103-13
4. Liu M, Pickles T, Agranovich A et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys 2004;58:59-67
5. Wachter S, Gerstner N, Goldner G et al. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol 2001;59:65-70
6. Valdagni R, Vavassori V, Rancati T et al. Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol 2012;103:252-5
7. Zelefsky MJ, Levin EJ, Hunt M et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124-9
8. Michalski JM, Gay H, Jackson A et al. Radiation dosevolume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010;76:S123-9
9. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer V1 2011. http://www.nccn.org/ (10 April 2012, data last accessed)
10. Sheets NC, Goldin GH, Meyer AM et al. Intensitymodulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 2012;307:1611-20
11. Tomita N, Soga N, Ogura Y et al. Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer. J Cancer Res Clin Oncol 2012;138: 1931-6
12. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6
13. Crehange G, Mirjolet C, Gauthier M et al. Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer. Radiother Oncol 2012;103:244-6
14. Kuban DA, Tucker SL, Dong L et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:67-74
15. Tucker SL, Dong L, Michalski JM et al. Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. Int J Radiat Oncol Biol Phys 2012;84:390-5
16. Pederson AW, Fricano J, Correa D et al. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys 2012;82:235-41
17. Takemoto S, Shibamoto Y, Ayakawa S et al. Treatment and prognosis of patients with late rectal bleeding after intensitymodulated radiation therapy for prostate cancer. Radiat Oncol 2012;7:87